Live Breaking News & Updates on Insider Activity At Corbus Pharmaceuticals

Stay updated with breaking news from Insider activity at corbus pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Expands By 560.9%

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Expands By 560.9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News Ratings For Corbus Pharmaceuticals Daily , Hedge Funds Weigh In On Corbus Pharmaceuticals , Insider Activity At Corbus Pharmaceuticals , Corbus Pharmaceuticals Holdings Inc , Corbus Pharmaceuticals , Corbus Pharmaceuticals Price Performance , Vident Investment Advisory , Jefferies Financial Group , Blackrock Inc , Renaissance Technologies , Corbus Pharmaceuticals Holdings , Get Free Report , Financial Group , Cormorant Asset Management , Sigma Investments , Street Corp , Investment Advisory , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily ,

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Expands By 560.9%

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 403,800 shares, a growth of 560.9% from the February 29th total of 61,100 shares. Based on an average daily volume of 886,400 […] ....

Corbus Pharmaceuticals , Insider Activity At Corbus Pharmaceuticals , Hedge Funds Weigh In On Corbus Pharmaceuticals , Blackrock Inc , Corbus Pharmaceuticals Price Performance , Corbus Pharmaceuticals Holdings Inc , News Ratings For Corbus Pharmaceuticals Daily , Renaissance Technologies , Jefferies Financial Group , Vident Investment Advisory , Corbus Pharmaceuticals Holdings , Get Free Report , Financial Group , Cormorant Asset Management , Sigma Investments , Street Corp , Investment Advisory , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily ,

Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded by StockNews.com to Hold

StockNews.com upgraded shares of Corbus Pharmaceuticals (NASDAQ:CRBP – Free Report) from a sell rating to a hold rating in a research note published on Saturday. Separately, Oppenheimer raised their price target on Corbus Pharmaceuticals from $20.00 to $51.00 and gave the stock an outperform rating in a research report on Monday, January 29th. Get Our […] ....

Corbus Pharmaceuticals Stock Down , Dimensional Fund Advisors , Corbus Pharmaceuticals Holdings Inc , Insider Activity At Corbus Pharmaceuticals , Renaissance Technologies , Institutional Trading Of Corbus Pharmaceuticals , Corbus Pharmaceuticals , Vident Investment Advisory , Securities Exchange Commission , News Ratings For Corbus Pharmaceuticals Daily , Free Report , Pharmaceuticals Stock Down , Get Free Report , Cormorant Asset Management , Exchange Commission , Sigma Investments , Fund Advisors , Investment Advisory , Street Corp , Pharmaceuticals Holdings , Corbus Pharmaceuticals Daily , Nasdaq Crbp , Stocknews Com ,